100% success for Ovarian Cancer Trial

The K9MD Team are thrilled to announce the results of a recent Proof of Concept validation for the detection of Ovarian cancer. This is a blind randomised trial designed and analysed by our biostatistician and independently reviewed. The trial was held over 4 consecutive days with K9 Hogan checking 300 samples.

The results are 100% success for sensitivity (correctly identifying all samples with cancer) and 100% success for specificity (correctly ignoring all samples that did not have cancer).

Congratulations to Hogan’s trainer Peter Hanlin and the entire K9MD Team.